Evaluating Hepatic Toxicity of Chitosan and Chitosan- Functionalized Iron Oxide Nanoparticles in a Rat Model of Peripheral Nerve Injury — Relevance for Rehabilitation Medicine
-
Published:2024-06-21
Issue:Vol.15, no. 2
Volume:15
Page:680-680
-
ISSN:2734-8458
-
Container-title:Balneo and PRM Research Journal
-
language:en
-
Short-container-title:
Author:
Pop Nadina Liana1, Nan Alexandrina2, Florea Adrian3, Toma Vlad Alexandru4, Moldovan Remus1, Decea Nicoleta1, Urda-Cimpean Andrada Elena5, Orasan Remus1, Mitrea Daniela Rodica1
Affiliation:
1. Department of Physiology, Iuliu Hațieganu University of Medicine and Pharmacy Cluj-Napoca 2. National Institute for Research and Development of Isotopic and Molecular Technologies 3. Department of Cell and Molecular Biology, Iuliu Hatieganu University of Medicine and Pharmacy 4. 4 Department of Molecular Biology and Biotechnologies, Babes-Bolyai University 5. 6 Department of Informatics and Biostatistics, Iuliu Hatieganu University of Medicine and Pharmacy Cluj-Napoca
Abstract
Background: Peripheral nerve injuries (PNI) can generate important medium- and long-term disability, as patients mostly complain about associated pain, sensibility and, or motor deficit, and even psychological manifestations. Chitosan and different nanoparticles types were previously used in several studies as treatment of peripheral nerve injuries. The present study aimed to assess the hepatic responses at oral administration of simple chitosan solution and of magnetic iron oxide nanoparticles functionalized with chitosan (CMNPs) solution in an experimentally induced peripheral nerve injury. (2) Methods: Chitosan or CMNPs were oral administrated, for 21 days, to animals with peripheral nerve injury. The treated groups were compared with a control group (peripheric nerve injury without any treatment). The hepatic toxicity of administered solutions was analyzed histologically, through transmission electron microscopy (TEM) and through the oxidative stress parameters, in comparison with the control group. (3) Results: Liver tissue histological evaluation showed non-significant degeneration of hepatocytes in Chitosan group and, in CMNPs group, slight periportal inflammation. TEM investigation revealed nuclear and mitochondrial polymorphism and lipid accumulation in hepatocytes in Chitosan group, and in CMNPs group, irregular nucleus profiles and increased glycogen storage in cytosol. Oxidative stress analysis showed antioxidant hepatic effect of both treatments. (4) Conclusions: Compared to control group, both treatments produced significant increases of hepatic antioxidant protection, probably induced by chitosan properties. Histological modifications of the liver were minimal for both treatment groups. TEM investigation showed unspecific alterations of the hepatocytes structure.
Keywords: chitosan; iron oxide magnetic nanoparticles; peripheral nerve injury; toxicity
Publisher
Romanian Association of Balneology
Reference44 articles.
1. 1. Pop, N.L., Mitrea, D.R., Urda-Cimpean, A.E., Filip, A., Clichici, S., Orasan, R. Peripheral nerve injury rehabilitation. Health, Sports & Rehabilitation Medicine 2020, 21, 244-251. 2. 2. Yifan, C. Chitosan composites nerve conduits. E3S Web of Conferences, ChinaBiofilms 2019, 1-6. 3. 3. Boecker, A., Daeschler, S.C., Kneser, U., Harhaus, L. Relevance and recent developments of chitosan in peripheral nerve surgery. Front. Cell. Neurosci 2019, 13, 104. 4. 4. Gruettner, C.; Muller, K.; Teller, J.; Westphal, F. Synthesis and functionalisation of magnetic nanoparticles for hyperthermia applications. Int J Hyperth 2013, 29, 777–789. 5. 5. Shi, S., Ou, X., Cheng, D. Nanoparticle-facilitated therapy: advancing tools in peripheral nerve regeneration. Int J Nanomedicine 2024, 19, 19-34.
|
|